Zhao Tengwen, Du Li, Zhang Ziyang, Li Na, Wang Manman, Ren Qi
School of Public Health, North China University of Science and Technology, No. 21 Bohai Road, Caofeidian, Tangshan 063210, Hebei, China.
Anal Methods. 2020 Aug 21;12(31):3924-3932. doi: 10.1039/d0ay01025a. Epub 2020 Jul 28.
A novel polymeric monolith using N,N-dimethylaminoethyl methacrylate as the monomer and ethylene glycol dimethacrylate as the crosslinker was successfully synthesized in a syringe and applied for direct solid-phase extraction of four benzodiazepines (bromazepam, triazolam, midazolam and diazepam) from undiluted urine samples prior to high performance liquid chromatography. The monolith was characterized by scanning electron microscopy, Fourier transform infrared spectroscopy and nitrogen adsorption-desorption experiments. Moreover, extraction parameters, including loading, washing and eluting conditions were optimized. Under the optimized conditions, the proposed method obtained linear ranges of 2.0-500 ng mL with correlation coefficients (r) higher than 0.9997. The limits of detection (S/N = 3) and limits of quantification (S/N = 10) were 0.4-0.6 ng mL and 1.4-2.0 ng mL, respectively. The recoveries at three spiked levels ranged from 83.7% to 103% with the intra- and inter-day precisions from 0.6-7.6% to 2.7-9.8%. The present monolith allowed direct loading of crude urine samples without any filtration or dilution step. Besides, the sorbent offered an enhancement factor of 16.7-20.6 and was stable enough for ten replicate cycles of extraction/desorption of urine samples. The developed method presented an alternative strategy for the accurate and convenient determination of benzodiazepines in urine samples.
一种以甲基丙烯酸N,N-二甲氨基乙酯为单体、乙二醇二甲基丙烯酸酯为交联剂的新型聚合物整体柱在注射器中成功合成,并应用于在高效液相色谱分析之前直接从未稀释的尿液样本中固相萃取四种苯二氮卓类药物(溴西泮、三唑仑、咪达唑仑和地西泮)。通过扫描电子显微镜、傅里叶变换红外光谱和氮吸附-脱附实验对整体柱进行了表征。此外,还优化了包括上样、清洗和洗脱条件在内的萃取参数。在优化条件下,该方法的线性范围为2.0 - 500 ng/mL,相关系数(r)高于0.9997。检测限(S/N = 3)和定量限(S/N = 10)分别为0.4 - 0.6 ng/mL和1.4 - 2.0 ng/mL。三个加标水平下的回收率在83.7%至103%之间,日内和日间精密度分别为0.6 - 7.6%至2.7 - 9.8%。这种新型整体柱允许直接加载原始尿液样本,无需任何过滤或稀释步骤。此外,该吸附剂的增强因子为16.7 - 20.6,并且足够稳定,可用于尿液样本萃取/解吸的十次重复循环。所开发的方法为尿液样本中苯二氮卓类药物的准确便捷测定提供了一种替代策略。